Evaluation of Immunohistochemical Markers for Canine Testicular Tumors
World Small Animal Veterinary Association World Congress Proceedings, 2007
Jung-Hyang Sur; Du-Na Hwang; Chi-Ho Yu; Ji-Young Yhee; Geun-Seog Song; Sang-Jin Lee; Jung-Hyang Sur
Konkuk University
South Korea


Primary testicular tumors occur commonly in aged dogs. The principal tumors of canine testes are seminoma, Sertoli cell tumor, and Leydig cell tumor, occurring with almost equal frequency. Although testicular tumors are common in dogs, there are not enough studies on tumor markers in these.


In this study, we seek to determine that the combined tumor markers for human testicular tumors, placental alkaline phosphatase (PLAP), OCT-4, CD30, alpha-fetoprotein (AFP), inhibin, vimentin are also useful to detect the canine testicular tumors.


A total of 13 canine testicular tumors were obtained from surgical specimens. The 12 canine testicular tumors comprised 7 seminomas, 4 Sertoli cell tumors, and 1 Leydig cell tumors. HE staining and immunohistochemistry was performed. Primary antibodies of PLAP, OCT-4, CD30, AFP, inhibin, and vimentin were applied. The antibodies are commonly used to differentiate germ cell tumors from sex-cord stromal tumors in human.


AFP expression was observed in 1/7 (14.3%) seminomas, 4/4 (100%) Sertoli cell tumors, and 1/1 (100%) Leydig cell tumors. Inhibin was found in 1/7 (14.3%) seminomas, 4/4 (100%) Sertoli cell tumors, and 0/1 (0%) Leydig cell tumors. Vimentin was expressed in 2/7 (28.6%) seminomas, 4/4 (100%) Sertoli cell tumors, and 0/1 (0%) Leydig cell tumors. Unfortunately, PLAP, Oct-4, and CD30 were not expressed.


In this study, AFP, inhibin and vimentin are tumor markers having specificity and sensitivity for canine testicular tumors. These markers can function as ones for differential diagnoses of canine testicular tumors.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Jung-Hyang Sur
Konkuk University
South Korea

MAIN : Abstracts - Poster : Markers of Testicular Tumors
Powered By VIN